Less Ads, More Data, More Tools Register for FREE

Pin to quick picksApax Global Alpha Regulatory News (APAX)

  • This share is currently suspended. It was suspended at a price of 164.40
  • There is currently no data for APAX

Initiation research from QuotedData

10 Mar 2021 14:03

RNS Number : 8344R
Apax Global Alpha Limited
10 March 2021
 

Apax Global Alpha Limited - Initiation research from QuotedData

 

10th March 2021

 

An abundance of alpha

 

Apax Global Alpha (whose ticker is APAX, but to avoid any potential confusion with the manager has been abbreviated throughout this note as AGA) has been listed for just over five years, but has been in operation for well over a decade. AGA provides access to the private equity expertise of Apax Partners. It also has a portfolio of derived investments (debt and equity investments), which provides a unique differentiator for AGA, reduces cash drag and helps support an attractive dividend.

 

Full research:

https://quoteddata.com/research/apax-global-alpha-limited-abundance-alpha-qd/

 

This research is also available free on our website www.quoteddata.com where you will also find news, performance data and factsheets on every London listed Investment Company. QuotedData writes and distributes research on a number of quoted companies, facilitates meetings between those companies and existing and potential investors and assists in raising additional capital where required.

 

NB: Marten & Co was paid to produce this note on Apax Global Alpha Limited and it is for information purposes only. It is not intended to encourage the reader to deal in the security or securities mentioned in this report. Please read the important information at the back of this note. QuotedData is a trading name of Marten & Co Limited which is authorised and regulated by the FCA. Marten & Co is not permitted to provide investment advice to individual investors categorised as Retail Clients under the rules of the Financial Conduct Authority.

QUOTEDDATA123a Kings Road | London SW3 4PLTel: +44 (0) 20 3691 9430

www.quoteddata.com | research@quoteddata.com | www.martenandco.com 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAXBLFFFXLEBBE
Date   Source Headline
11th Sep 20247:00 amRNSTransaction in Own Shares
10th Sep 20247:00 amRNSTransaction in Own Shares
9th Sep 20247:00 amRNSTransaction in Own Shares
6th Sep 20245:01 pmRNSDirector/PDMR Shareholding
6th Sep 202411:14 amRNSDirector/PDMR Shareholding
6th Sep 20247:00 amRNSTransaction in Own Shares
5th Sep 20247:00 amRNS2024 Interim Dividend
5th Sep 20247:00 amRNS2024 Interim Results Highlights
4th Sep 20247:00 amRNSTransaction in Own Shares
4th Sep 20247:00 amRNSApax Funds invest in Altus Fire & Life Safety
3rd Sep 20247:00 amRNSTransaction in Own Shares
3rd Sep 20247:00 amRNSCreation of Sub-Committees of the Board
2nd Sep 20247:00 amRNSTransaction in Own Shares
30th Aug 20247:00 amRNSTransaction in Own Shares
29th Aug 20247:00 amRNSTransaction in Own Shares
29th Aug 20247:00 amRNSApax Funds to acquire Veriforce
21st Aug 20247:00 amRNSTransaction in Own Shares
20th Aug 20247:00 amRNSTransaction in Own Shares
19th Aug 20247:00 amRNSTransaction in Own Shares
16th Aug 20247:00 amRNSTransaction in Own Shares
15th Aug 20247:00 amRNSTransaction in Own Shares
14th Aug 20247:00 amRNSTransaction in Own Shares
13th Aug 20247:00 amRNSTransaction in Own Shares
12th Aug 20242:30 pmRNSDirector Declaration
12th Aug 20247:00 amRNSTransaction in Own Shares
12th Aug 20247:00 amRNSUpdate regarding Thoughtworks
9th Aug 20247:00 amRNSTransaction in Own Shares
8th Aug 20247:00 amRNSTransaction in Own Shares
7th Aug 20247:00 amRNSTransaction in Own Shares
7th Aug 20247:00 amRNSApax Funds to Acquire greytHR
6th Aug 20247:00 amRNSTransaction in Own Shares
6th Aug 20247:00 amRNSThoughtworks to be taken private by Apax Funds
6th Aug 20247:00 amRNSEstimated Adjusted NAV as at 30 June 2024
29th Jul 20247:00 amRNSTransaction in Own Shares
26th Jul 20247:00 amRNSTransaction in Own Shares
18th Jul 20247:00 amRNSApax X agrees to sell stake in AffiniPay
16th Jul 20247:00 amRNSApax IX sells remaining stake in BCG
11th Jul 20247:00 amRNSApax IX sells remaining stake in Genius Sports
4th Jul 20247:00 amRNSDirector Appointment
4th Jul 20247:00 amRNSTransaction in Own Shares
3rd Jul 20247:00 amRNSTransaction in Own Shares
2nd Jul 20247:00 amRNSTransaction in Own Shares
1st Jul 20247:00 amRNSApax X agrees to sell stake in idealista
1st Jul 20247:00 amRNSTransaction in Own Shares
28th Jun 20247:00 amRNSTransaction in Own Shares
26th Jun 20247:00 amRNSRetirement of Tim Breedon from the Board
26th Jun 20247:00 amRNSCommencement of Share Buyback Programme
26th Jun 20247:00 amRNSUpdate on Capital Allocation
16th May 20244:36 pmRNSPDMR Dealing – Share Transfers
16th May 20244:35 pmRNSPDMR Dealing - Share Transfers

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.